Insider Trading History of Zuerblis Kenneth J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Zuerblis Kenneth J since 2010. The trader's CIK number is 1007923. At the time of the last reporting, Zuerblis Kenneth J was the Director of Stemline Therapeutics Inc. (stock ticker symbol STML). Also see all insider trading activities at Stemline Therapeutics Inc.

Note that in the past ZUERBLIS KENNETH J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Stemline Therapeutics Inc (STML) by Zuerblis Kenneth J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 STML 1,000 $11,143 0 $0 0 $0
2013 STML 3,000 $48,041 0 $0 0 $0

Yearly summary of insider trading at Savient Pharmaceuticals Inc (SVNT) by Zuerblis Kenneth J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 SVNT 7,000 $24,847 0 $0 0 $0

Yearly summary of insider trading at Immunomedics Inc (IMMU) by Zuerblis Kenneth J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 IMMU 0 $0 0 $0 5,000 $0
2010 IMMU 0 $0 0 $0 4,167 $0


Insider trading activities at 3 companies by Zuerblis Kenneth J:

1. Stemline Therapeutics Inc (STML)

2. Savient Pharmaceuticals Inc (SVNT)

3. Immunomedics Inc (IMMU)

Table 1. Insider trading of Stemline Therapeutics Inc (STML) by Zuerblis Kenneth J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-09-02 STML Buy 1,000 11.14 11,143
2013-05-30 STML Buy 900 16.38 14,742
2013-05-29 STML Buy 2,100 15.86 33,299

Table 2. Insider trading of Savient Pharmaceuticals Inc (SVNT) by Zuerblis Kenneth J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-11-18 SVNT Buy 2,000 2.35 4,690
2011-09-15 SVNT Buy 4,000 4.05 16,187
2011-09-14 SVNT Buy 1,000 3.97 3,970

Table 3. Insider trading of Immunomedics Inc (IMMU) by Zuerblis Kenneth J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-12-07 IMMU Option Ex 5,000 .00 0
2010-12-01 IMMU Option Ex 4,167 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zuerblis Kenneth J (Director of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.